August
UNC scientists pinpoint how a single genetic mutation increases autism risk
The research shows the precise cellular mechanisms that could increase risk for the disorder and how an existing drug might help thousands of people with autism.
Scientists identify gene vital for rebuilding intestine after cancer treatment
Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
Your Excuse or Your Story
Thirteen months ago, incoming Carolina freshman Colin Thompson was on his way home to Houston from summer camp when he was involved in a life-threatening accident and air-lifted to an Austin hospital. Today, he's an outpatient at the UNC Center for Rehabilitation Care, and he's preparing to begin his college career.
Charlotte Charity Inspires New Law Designed to Spur Treatments for Rare Diseases and Economic Growth for North Carolina
Law Will Establish an Advisory Council on Rare Diseases at the University of North Carolina at Chapel Hill
Puppies: The Power of Cute for Mental Health
The UNC PAWS program of the UNC Center for Excellence in Community Mental Health trains puppies for 10 weeks and then matches each puppy with a veteran suffering from PTSD.
Comprehending Chemotaxis
James Bear, PhD, uncovers the intricate mechanisms that allow certain cells to move, discoveries with implications for cancer metastasis.
Landmark study validates method for patient reporting of cancer drug-related adverse events
In an article published in JAMA Oncology today, a study led by UNC Lineberger's Ethan Basch and colleagues shows that a system they developed accurately and reliably captures the patient experience with cancer drug side effects.
New study to explore possible links between gut bacteria and eating disorders
UNC’s part in the study is led by Dr. Cynthia M. Bulik, Distinguished Professor of Eating Disorders in the Department of Psychiatry in the School of Medicine, a Professor of Nutrition in the Gillings School of Global Public Health, and Founding Director of the UNC Center of Excellence for Eating Disorders.
Diabetes drug metformin’s primary effect is in the gut, not the bloodstream
New study in Diabetes Care suggests new delayed-release metformin could help 40 percent of type 2 diabetes patients that currently can’t take metformin.
Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator
The editors of the MIT Technology Review highlighted Gu’s work on a novel way to monitor and treat diabetes.
UNC’s Wolfgang Bergmeier, PhD, earns Bridge Grant
The American Society of Hematology fills gap in decreased federal funding, supports 13 blood research projects.
The Proof is in the Pudding
Temperance Rowell delves into the flavored world of e-cigarettes to investigate the long-term effects of a new trend.
UNC Health Care CEO William Roper Ranked No. 14 on Modern Healthcare’s Annual List of 100 Most Influential People in Healthcare
Dr. Roper is the highest ranked CEO of a public academic health system on the list.
All About Family
David Bueso moved to the United States with his family more than 15 years ago. He began working at UNC Hospitals shortly thereafter. Not only has he made a name for himself in the Emergency Department, he’s also found a work family.
Alice Ma Delivers Whitehead Lecture
Alice Ma, MD, associate professor, department of medicine, division of hematology-oncology, delivered this year's Whitehead Lecture. The themes of Ma’s lecture closely followed its title: “Endurance, Obstacles, Perseverance and Joy: My Transformation from the World’s Crummiest Medical Student to Faculty at the World’s Best Medical School.”
Six UNC Hospitals residency programs nationally ranked by Doximity
UNC’s residency programs in Family Medicine, Obstetrics and Gynecology, Otolaryngology, Pediatrics, Radiation Oncology and Urology are all ranked in the top 25 programs nationwide in the Doximity Residency Navigator.
UNC Hospitals resident physician launches #ILookLikeASurgeon
Heather Logghe, MD, a resident in surgery at UNC Hospitals, created a hashtag that sparked a worldwide movement.
Falk receives funding to extend kidney disease project
This award allows a multidisciplinary team led by Ronald Falk, MD, to continue its research of glomerulonephritis and vasculitis caused by anti-neutrophil cytoplasmic antibodies (ANCA), which is the most common form of rapidly progressing glomerular disease. The latest competitive renewal will carry the study to its 20th year.